United Kingdom· GB-APID-45791211000001102

Safinamide 50mg tablets

A safinamide product containing safinamide, registered in United Kingdom by A A H Pharmaceuticals Ltd. The same ATC class is registered in 17 of our 19 countries.

ATC N04BD03

Checked against NHS dm+d (United Kingdom) on September 13, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about safinamideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Safinamide is registered in 17 of 19 countries.

Countries holding a registration under ATC N04BD03 (safinamide), each read from that country’s own register.

This record: United Kingdom, from NHS dm+d (United Kingdom)
10 of them publish a price we can compare per daily dose

Search safinamide products by name

Safinamide · ATC N04BD03

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of safinamide costs, country by country.

Normalised to the WHO defined daily dose (75 mg), the median price runs from $2.78 in Spain to $5.29 in Italy — a ×1.9 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Safinamide · price per daily dose (75 mg)

USD · FX 28 Sept 2026

IT Italy$5.29
CH Switzerland$4.79
ES Spain$2.78

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)

Active substance: Safinamide
Manufacturer: A A H Pharmaceuticals Ltd
Country: United Kingdom (GB)
ATC code: N04BD03
ATC class: Safinamide
Defined daily dose: 75 mg, O
Reimbursed: Not published by this register
Source register: NHS dm+d (United Kingdom)
Last checked: September 13, 2026

Packs & prices · 1

gtin
5025903041115

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

158 interactions on record for safinamide.

Graded by severity as the source publishes them — 18 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check safinamide against other medicines How interaction checks work

Safinamide · interactions on record

158 records

18 severe
140 moderate

Most severe, free to view

FenfluramineA08AA02severe
DexfenfluramineA08AA04severe
SibutramineA08AA10severe
DoxepinD04AX01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Safinamide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All safinamide products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

Belgium · Safinamide Ab, Safinamide Eg
Cyprus · Orvago
Germany · Safinamid Al, Safinamid Puren
Denmark · Safinamid Vivanta
Estonia · Safinamide Teva
Spain · Safinamida Aurovitas, Safinamida Cinfa
Finland · Safinamide Vivanta
Greece · Orvago, Safinamide Win Medica
Croatia · Safinamid Msn, Safinamide Msn
Iceland · Xadago
Italy · Safinamide Aurobindo, Safinamide Doc
Liechtenstein · Xadago
Lithuania · Safinamide Teva
Luxembourg · Safinamide Eg
Latvia · Safinamide Teva
Malta · Safinamide Nio
Netherlands · Safinamide Vivanta
Norway · Safinamide Vivanta, Xadago
Portugal · Safinamida Aurobindo, Safinamida Generis
Sweden · Orvago, Safinamid Doc

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/096e97ae-d28e-421b-9a9c-b0fb4c932a05
GET /v1/drugs/096e97ae-d28e-421b-9a9c-b0fb4c932a05?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "45791211000001102",
  "desc": "Safinamide 50mg tablets (A A H Pharmaceuticals Ltd)",
  "form": "Oral tablet",
  "vpid": "32696511000001102",
  "source": "dmd",
  "vtm_id": "777482000",
  "strength": "50 mg",
  "substance": "Safinamide",
  "ingredient": "Safinamide mesilate",
  "supplier_code": "3144701000001104"
}

API reference MCP server Plans

See everything about safinamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console